Lotus Eye Hospital (LOTUSEYE) | Stock Overview & Key Data
Lotus Eye Hospital Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹147.00 on January 30, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Lotus Eye Hospital
LOTUSEYE
|
2.63B Small-cap | 18.71% | 31.36% | 30.60% | 6.44% | 16.21% | 87.80% | 65.97% | 207.74% | 690.06% | 1,106.25% | 278.96% |
|
Apollo Hospitals
APOLLOHOSP
|
1.12T Large-cap | 1.38% | 4.79% | 13.08% | 19.52% | 19.10% | 21.50% | 63.42% | 163.79% | 556.24% | 1,658.87% | 4,106.51% |
|
Max Healthcare
MAXHEALTH
|
979.76B Large-cap | 2.13% | -2.02% | 6.01% | -5.21% | -1.95% | -17.87% | 70.33% | 304.25% | 806.00% | 806.00% | 806.00% |
|
Indraprastha Medical
INDRAMEDCO
|
37.31B Small-cap | -0.95% | 4.95% | -1.44% | -21.11% | -14.34% | -5.84% | 323.69% | 338.93% | 635.89% | 971.03% | 1,203.39% |
|
Dr. Agarwal's Eye
DRAGARWQ
|
24.28B Small-cap | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
|
Shalby
SHALBY
|
16.70B Small-cap | -0.43% | 7.91% | 21.73% | -12.46% | -15.93% | -6.18% | 10.56% | 5.52% | -29.49% | -29.49% | -29.49% |
Ownership & Short Interest
Calculate Your Lotus Eye Hospital Investment Returns
Long-Term Investment Performance Analysis
Lotus Eye Hospital stock price in Aug 2016 was ₹15.85, A ₹1,000.00 lump sum investment in Lotus Eye Hospital made 9 years ago would be worth approximately ₹8,831.55 today, representing a exceptional return of 783.15%. This translates to an annualized return (CAGR) of 24.70%.
9 Years 10 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is LOTUSEYE's 52-week high and low?
- In the last 52 weeks, Lotus Eye Hospital reached a high of ₹147.00 (on January 30, 2026) and a low of ₹67.72 (on June 19, 2025).
- What is the market cap and P/E ratio for LOTUSEYE?
- Curious about Lotus Eye Hospital's size and valuation? Its market capitalization stands at 2.63B. When it comes to valuation, the P/E ratio (trailing twelve months) is 371.78, and the forward P/E (looking ahead) is N/A.
- Does LOTUSEYE pay dividends? If so, what's the yield?
- As for dividends, Lotus Eye Hospital isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Lotus Eye Hospital's main competitors or similar companies to consider before investing?
When looking at Lotus Eye Hospital, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Apollo Hospitals
APOLLOHOSP1.12T Healthcare Medical Care Facilities 21.50% 63.42% Max Healthcare
MAXHEALTH979.76B Healthcare Medical Care Facilities -17.87% 70.33% Indraprastha Medical
INDRAMEDCO37.31B Healthcare Medical Care Facilities -5.84% 323.69% Dr. Agarwal's Eye
DRAGARWQ24.28B Healthcare Medical Care Facilities 12.35% 240.02% Shalby
SHALBY16.70B Healthcare Medical Care Facilities -6.18% 10.56% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lotus Eye Hospital and Institute Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Lotus Eye Hospital's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.23%, the Debt to Equity ratio from the most recent quarter is 7.92, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for LOTUSEYE?
- Looking at Lotus Eye Hospital's growth, its revenue over the trailing twelve months (TTM) was INR516M. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.60%, and quarterly earnings saw a YoY growth of N/A.
- How much of LOTUSEYE stock is held by insiders and institutions?
- Wondering who owns Lotus Eye Hospital stock? Company insiders (like executives and directors) hold about 71.94% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.